Hallucinogens
- PMID: 14761703
- DOI: 10.1016/j.pharmthera.2003.11.002
Hallucinogens
Abstract
Hallucinogens (psychedelics) are psychoactive substances that powerfully alter perception, mood, and a host of cognitive processes. They are considered physiologically safe and do not produce dependence or addiction. Their origin predates written history, and they were employed by early cultures in a variety of sociocultural and ritual contexts. In the 1950s, after the virtually contemporaneous discovery of both serotonin (5-HT) and lysergic acid diethylamide (LSD-25), early brain research focused intensely on the possibility that LSD or other hallucinogens had a serotonergic basis of action and reinforced the idea that 5-HT was an important neurotransmitter in brain. These ideas were eventually proven, and today it is believed that hallucinogens stimulate 5-HT(2A) receptors, especially those expressed on neocortical pyramidal cells. Activation of 5-HT(2A) receptors also leads to increased cortical glutamate levels presumably by a presynaptic receptor-mediated release from thalamic afferents. These findings have led to comparisons of the effects of classical hallucinogens with certain aspects of acute psychosis and to a focus on thalamocortical interactions as key to understanding both the action of these substances and the neuroanatomical sites involved in altered states of consciousness (ASC). In vivo brain imaging in humans using [(18)F]fluorodeoxyglucose has shown that hallucinogens increase prefrontal cortical metabolism, and correlations have been developed between activity in specific brain areas and psychological elements of the ASC produced by hallucinogens. The 5-HT(2A) receptor clearly plays an essential role in cognitive processing, including working memory, and ligands for this receptor may be extremely useful tools for future cognitive neuroscience research. In addition, it appears entirely possible that utility may still emerge for the use of hallucinogens in treating alcoholism, substance abuse, and certain psychiatric disorders.
Similar articles
-
Psychedelics.Pharmacol Rev. 2016 Apr;68(2):264-355. doi: 10.1124/pr.115.011478. Pharmacol Rev. 2016. PMID: 26841800 Free PMC article. Review.
-
Hallucinogens, serotonin and obsessive-compulsive disorder.J Psychoactive Drugs. 1998 Oct-Dec;30(4):359-66. doi: 10.1080/02791072.1998.10399711. J Psychoactive Drugs. 1998. PMID: 9924841 Review.
-
Cellular mechanisms of serotonin 5-HT2A receptor-mediated cGMP formation: the essential role of glutamate.Brain Res. 2004 Apr 2;1003(1-2):168-75. doi: 10.1016/j.brainres.2004.01.014. Brain Res. 2004. PMID: 15019576
-
Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.Psychiatr Clin North Am. 2006 Jun;29(2):371-90. doi: 10.1016/j.psc.2006.02.007. Psychiatr Clin North Am. 2006. PMID: 16650714 Review.
-
In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.Prog Brain Res. 2008;172:177-97. doi: 10.1016/S0079-6123(08)00909-6. Prog Brain Res. 2008. PMID: 18772033 Review.
Cited by
-
Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms.Psychopharmacology (Berl). 2024 Apr 30. doi: 10.1007/s00213-024-06585-x. Online ahead of print. Psychopharmacology (Berl). 2024. PMID: 38687360
-
Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT2A Receptor Agonists.J Med Chem. 2024 May 9;67(9):7224-7244. doi: 10.1021/acs.jmedchem.4c00082. Epub 2024 Apr 22. J Med Chem. 2024. PMID: 38648420 Free PMC article.
-
Scoping Review: The Role of Psychedelics in the Management of Chronic Pain.J Pain Res. 2024 Mar 11;17:965-973. doi: 10.2147/JPR.S439348. eCollection 2024. J Pain Res. 2024. PMID: 38496341 Free PMC article. Review.
-
Exploring Novel Antidepressants Targeting G Protein-Coupled Receptors and Key Membrane Receptors Based on Molecular Structures.Molecules. 2024 Feb 22;29(5):964. doi: 10.3390/molecules29050964. Molecules. 2024. PMID: 38474476 Free PMC article. Review.
-
Race, Ethnic, and Sex Differences in Prevalence of and Trends in Hallucinogen Consumption Among Lifetime Users in the United States Between 2015 and 2019.Front Epidemiol. 2022 Mar 23;2:876706. doi: 10.3389/fepid.2022.876706. eCollection 2022. Front Epidemiol. 2022. PMID: 38455323 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous